Efficacy Study of GLYC-101 to Evaluate Outcomes After Post-laser Ablation

NCT00656474 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Wounds

Interventions

DRUG: Placebo gel
DRUG: GLYC-101 gel (1.0 %)

Sponsor

TR Therapeutics